We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info . X close

Residual DNA Testing Market: Growth, Size, Share, and Trends

Report Code BT 9405
Published in Jun, 2025, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Residual DNA Testing Market by Product & Service (Consumable, Instrument & Software), Technology (PCR), Test Type (Raw, Final, Bulk Lot Release Testing), Application (mAb, CGT, Vaccine), End User (Pharma & Biotech, CRO & CDMO) - Global Forecast to 2030

Overview

The global residual DNA testing market, valued at US$0.27 billion in 2024, stood at US$0.28 billion in 2025 and is projected to advance at a resilient CAGR of 6.0% from 2025 to 2030, culminating in a forecasted valuation of US$0.37 billion by the end of the period. The residual DNA testing market is undergoing substantial expansion, largely propelled by a rising number of approvals for biosimilars and biologics. This growth is further augmented by stringent regulatory mandates imposed by global regulatory bodies, including the US FDA, EMA, and ICH. Additionally, advancements in technologies and an uptick in research and development investments are significantly contributing to the momentum of this market segment.

Residual DNA Testing Market – Global Forecast and Key Opportunities to 2030

Attractive Opportunities in the Residual DNA Testing Market

Asia Pacific

The growth of the Asia Pacific residual DNA testing market is primarily due to increasing number of fundings and investments by pharmaceutical and biotechnology companies for the advancement of the healthcare sector. Additionally, emerging markets in the Asia Pacific is set to enhance the residual DNA testing market growth.

The key factors driving the market growth include a rising number of approvals for biosimilars and biologics for the treatment of chronic diseases.

The stringent regulatory requirements setup by regulatory authorities mandates residual DNA testing in biologics manufacturing.

The technological advancements in DNA quantification and detection are expected to offer an impetus to market growth during the forecast period.

The Asia Pacific region ranks first in terms of CAGR, with key revenue contributing countries including China, Japan, and India.

Global Residual DNA Testing Market Dynamics

DRIVER: Increase in biologics and biosimilar approvals

The global biopharmaceutical market is witnessing significant expansion, driven by the increasing prevalence of chronic diseases and the growth of biologics and biosimilars. This trajectory is bolstered by the introduction of innovative biologics-based therapies and sustained revenue from established products. Current market forecasts indicate that biopharmaceuticals will capture a substantial portion of the global pharmaceuticals sector in the coming years. The demand for biologics and biosimilars is further enhanced by advancements in cell and gene therapies, as well as recombinant therapeutics designed to address complex and chronic conditions. The industry's transition from small-molecule drugs to biologics necessitates the establishment of rigorous quality assurance and regulatory compliance protocols. A critical component of these protocols is residual DNA testing, which is essential for ensuring the safety, efficacy, and purity of biologics by monitoring trace levels of host cell DNA. As the rate of approvals for biologics and biosimilars increases, coupled with the patent expirations of traditional pharmaceuticals, there has been a corresponding rise in manufacturing activities. This uptick drives a heightened demand for analytical instruments, particularly for residual DNA testing. Regulatory agencies continue to emphasize stringent quality standards, making these testing methods increasingly pivotal in the biopharmaceutical manufacturing process and in lot release protocols.

RESTRAINT: Lack of standardization across testing protocols

The primary constraint hindering the growth of the residual DNA testing market is the absence of standardized testing methodologies across various regions, product categories, and manufacturing processes. Regulatory authorities globally have established general safety thresholds for residual host cell DNA, providing a diverse set of protocols for conducting safety assessments. However, significant variability exists in assay design, DNA extraction methods, quantitation techniques, and validation protocols among different manufacturers, which contributes to the overall lack of standardization in residual DNA testing practices. This variability, which is often permitted within regulatory frameworks, leads to inconsistent methodologies that complicate the comparison of results across laboratories, manufacturing sites, and geographical locations. Key factors contributing to this inconsistency include discrepancies in sample preparation methods, the choice of analytical platforms, reference standards utilized, and the determination of detection limits. Such deviations undermine the reproducibility and comparability of data, particularly in contexts involving multinational operations or the development of biosimilars. The lack of harmonization presents both regulatory and operational challenges, impeding various phases of product development, including scaling up manufacturing processes and navigating regulatory submissions. Consequently, these discrepancies restrict the broader adoption and scalability of residual DNA testing solutions within the biopharmaceutical sector.

 

OPPORTUNITY: Growth opportunities in emerging markets

Emerging markets such as China, India, Japan, and Brazil present significant growth potential for the residual DNA testing sector, driven primarily by the rapid advancement of the biopharmaceutical industry in the Asia Pacific and Latin America. The increasing collaboration between established corporations and small to medium-sized enterprises (SMEs) in the realm of biologics development is catalyzing the demand for precision detection and analytical tools. As the biopharmaceutical pipeline expands, particularly in the areas of biosimilars, vaccines, and advanced therapeutic modalities, the need for residual DNA testing is expected to rise correspondingly. These emerging economies are strategically positioning themselves to meet global regulatory requirements while enhancing quality assurance capabilities, thus creating a conducive environment for integrating residual DNA testing technologies within manufacturing and quality control protocols. A noteworthy example of this trend is Sun Pharma's acquisition of Concert Pharmaceuticals in March 2023, which aims to bolster its R&D capabilities in immunotherapy and targeted oncology. Such collaborative initiatives between local and international stakeholders in the residual DNA testing market are poised to accelerate industry growth, reflecting an increasingly favorable landscape for stakeholders in this sector.

CHALLENGES: Complexity in sample preparation and assay validation

The residual DNA testing market faces significant challenges primarily due to the complexities involved in sample preparation and assay validation. Optimizing these processes is crucial to achieving the accuracy, sensitivity, and specificity required for detecting trace levels of host cell DNA in biologics. Assay development must adhere to stringent regulatory standards, making the overall process technically intricate and resource-intensive. Effective sample preparation is critical to prevent contamination, ensure optimal recovery, and preserve the integrity of the target DNA. Any deviation from established extraction protocols can compromise downstream analyses, leading to unreliable and potentially misleading results. Assay validation entails several key steps, including the determination of detection limits, assessment of matrix effects, confirmation of specificity for host cell DNA, and demonstration of reproducible assay performance across different batches. A recent white paper published by RSSL in March 2024 underscored the inherent difficulties in validating residual DNA assays, particularly regarding the reliable detection of high levels of mobile host DNA in biologics. As the field advances, novel methodologies are anticipated to mitigate these challenges, enhancing assay performance and reliability in the future.

Global Residual DNA Testing Market Ecosystem Analysis

The ecosystem of the residual DNA testing market comprises supply side as well as demand-side entities that significantly contribute towards market growth. This ecosystem comprises raw material suppliers, product manufacturers, service providers, end users, and regulatory bodies. The demand side entities for residual DNA testing products include pharmaceutical & biotechnology companies, CROs & CDMOs, and academic & research institutes.

Residual DNA Testing Market Ecosystem
 

By offering, the products segment commanded a larger market share in 2024.

On the basis of offerings, the residual DNA testing market is divided into products and services. In 2024, the products segment was the predominant contributor to the residual DNA testing market, driven by several key factors within the biopharmaceutical sector. The rapid advancement of this industry, coupled with the increasing demand for biologics and intensified research into the development of monoclonal antibodies, cell and gene therapies, and vaccines, has fueled this segment's growth.

Biologics are crucial in addressing chronic conditions such as cardiovascular and neurodegenerative diseases, leading to widespread adoption across various therapeutic modalities. Regulatory bodies, including the US Food and Drug Administration (FDA), European Medicines Agency (EMA), and the International Council for Harmonization (ICH), have established stringent guidelines concerning acceptable levels of residual host cell DNA in final drug formulations. These regulatory requirements are vital for ensuring product safety and efficacy, propelling the demand for innovative residual DNA testing solutions.

Furthermore, the expansion of biopharmaceutical production on a global scale has increased the need for high-performance, reliable testing kits, reagents, and instruments capable of detecting and quantifying trace amounts of host cell DNA efficiently.

By application, the monoclonal antibodies accounted for the largest market share in 2024.

On the basis of application, the residual DNA testing market is segmented into monoclonal antibodies (mAbs), cell & gene therapy, vaccines, and other applications. In 2024, the mAbs application segment dominated the global residual DNA testing market. This sector is driven by the expanding use of mAbs in oncology, autoimmune disorders, and infectious diseases. The growing number of originator and biosimilar mAb development and approvals has intensified the focus on stringent quality control measures, such as residual DNA testing, within biomanufacturing processes. As several high-value biologics approach patent expiration, there is a notable surge in biosimilar development. Regulatory bodies, including the FDA and EMA, now mandate comprehensive residual DNA testing as a critical component of their evaluation processes, underlining the necessity for validated and accurate testing methodologies. Furthermore, advancements in upstream bioprocessing, particularly through the adoption of intensified platforms like perfusion bioreactors, have led to increased DNA burdens due to extended culture durations and higher cell density. This evolution necessitates robust downstream purification strategies and the incorporation of residual DNA analysis to ensure compliance with regulatory standards. Additionally, the prevalent use of Chinese Hamster Ovary (CHO) cells, a well-established source of host cell DNA, underscores the significance of residual DNA testing in maintaining product integrity and regulatory adherence.

North America has emerged as the highest revenue-generating market in the residual DNA testing market in 2024.

The global residual DNA testing market is categorized into six key regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In 2024, North America emerged as the leading region in this market, followed by Europe and the Asia Pacific. This dominance is primarily due to the robust biopharmaceutical R&D infrastructure in the region, particularly in the United States and Canada. The US holds the largest share of the North American market, driven by substantial investments in R&D focused on biotechnological and pharmaceutical innovations. North America also excels in biologics production capacity, encompassing monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. The anticipated increase in demand for advanced therapeutic solutions correlates with rising incidences of chronic and age-related diseases. Additionally, numerous global players, including Thermo Fisher Scientific Inc., Maravai LifeSciences, Bio-Rad Laboratories, and Charles River Laboratories, bolsters the region's significant market share. The Asia Pacific region is forecasted to exhibit the highest compound annual growth rate (CAGR) during the upcoming years, highlighting its growing influence in the residual DNA testing sector.

NORTH AMERICA ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2024
US IS THE FASTEST-GROWING MARKET IN THE REGION
Residual DNA Testing Market Region

Recent Developments of Residual DNA Testing Market

  • Expansion: In April 2025, Thermo Fisher Scientific, Inc. announced the opening of its Advanced Therapies Collaboration Center (ATxCC) in California, US. This facility is designed to accelerate the development and commercialization of cell therapies.
  • Acquisition: In February 2025, Bio-Rad Laboratories, Inc. acquired Stilla Technologies to strengthen its digital PCR portfolio, with applications in cell and gene therapy, residual DNA testing, and infectious disease detection.
  • Product Launch: In September 2024, Qiagen launched 100 new assays for its digital PCR (dPCR) platform, QIAcuity, to enable accurate and sensitive detection of low-abundance pathogens, copy number alterations, and identification of rare mutations.
  • Collaboration: In August 2024, Cygnus Technologies, a subsidiary of Maravai LifeSciences, entered into a collaboration with TriLink BioTechnologies to launch AccuRes Host Cell DNA Quantification Kits.

Key Market Players

Want to explore hidden markets that can drive new revenue in Residual DNA Testing Market?

Scope of the Report

Report Metric Details
Market size available for years 2023-2030
Base Year Considered 2024
Forecast period 2025-2030
Forecast units Value (USD Million)
Segments covered Offering, Technology, Test Type, Application, End User (Product), End User (Service), and Region
Geographies covered North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa

Frequently Asked Questions (FAQ)

Who are the key players in the residual DNA testing market?

Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Eurofins Scientific (Luxembourg), Charles River Laboratories (US), Bio-Rad Laboratories, Inc. (US), QIAGEN (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Maravai LifeSciences (US), FUJIFILM Corporation (Japan), SGS Société Générale de Surveillance SA. (Switzerland), Jiangsu Hillgene Biopharma Co., Ltd (China), Revvity (US), Intertek Group plc (UK), WuXi AppTec (China), Sartorius AG (Germany), and Lonza (Switzerland).

Which product segment dominates the residual DNA testing market?

Consumables are expected to dominate the market in the product segment, driven by the recurring nature of demand.

Which application segment of the residual DNA testing market is expected to witness the highest growth?

The cell & gene therapies applications segment is expected to register the highest growth during the forecast period, mainly due to regulatory requirements and the complexity of viral vector-based production systems.

Which end user segment of the residual DNA testing market is expected to witness the highest growth?

Pharmaceutical & biotechnology companies accounted for the largest market share and the highest growth by end users in 2024 due to the stringent regulatory requirements for product safety and quality.

What is the market size for the residual DNA market?

The global residual DNA testing market is projected to reach USD 0.37 billion by 2030 from USD 0.28 billion in 2025, at a CAGR of 6.0% during the forecast period.

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Residual DNA Testing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
36
RESEARCH METHODOLOGY
40
EXECUTIVE SUMMARY
52
PREMIUM INSIGHTS
57
MARKET OVERVIEW
60
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Increasing number of biologics and biosimilar approvals
    - Stringent regulatory compliance requirements
    - Technological advancements in DNA quantification and detection
    - Increasing risk of cell culture contamination
    - Rising biopharmaceutical R&D investments
    RESTRAINTS
    - High costs of advanced testing techniques
    - Lack of standardization across testing protocols
    OPPORTUNITIES
    - Rising number of applications in novel modalities
    - High growth opportunities in emerging markets
    - Integration with continuous and accelerated bioprocessing
    - Rising outsourcing to CROs and CDMOs
    CHALLENGES
    - Complexity in sample preparation and assay validation
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
  • 5.4 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND OF RESIDUAL DNA TESTING PRODUCTS, BY KEY PLAYER, 2022–2024
    AVERAGE SELLING PRICE TREND OF RESIDUAL DNA TESTING PRODUCTS, BY REGION, 2022–2024
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 ECOSYSTEM ANALYSIS
    ROLE IN ECOSYSTEM
  • 5.7 INVESTMENT & FUNDING SCENARIO
  • 5.8 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Quantitative PCR (qPCR)
    - Droplet digital PCR (ddPCR)
    - Next-generation sequencing (NGS)
    COMPLEMENTARY TECHNOLOGIES
    - Automated magnetic bead-based DNA extraction
    - Capillary electrophoresis
    - Nanopore sequencing
    ADJACENT TECHNOLOGIES
    - High-performance liquid chromatography (HPLC)
    - Electron microscopy
    - Mass spectrometry
  • 5.9 PATENT ANALYSIS
    LIST OF KEY PATENTS
  • 5.10 KEY CONFERENCES & EVENTS, 2025–2026
  • 5.11 REGULATORY ANALYSIS
    REGULATORY FRAMEWORK
    - North America
    - Europe
    - Asia Pacific
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.12 PORTER’S FIVE FORCES ANALYSIS
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.13 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    KEY BUYING CRITERIA, BY END USER
  • 5.14 IMPACT OF AI/GEN AI ON RESIDUAL DNA TESTING MARKET
    MARKET POTENTIAL OF AI IN RESIDUAL DNA TESTING
    AI USE CASES
    KEY COMPANIES IMPLEMENTING AI/GEN AI
    FUTURE OF AI/GEN AI IN RESIDUAL DNA TESTING MARKET
  • 5.15 TRADE DATA ANALYSIS
    IMPORT DATA FOR HS CODE 9027, 2020–2024
    EXPORT DATA FOR HS CODE 9027, 2020–2024
  • 5.16 IMPACT OF 2025 US TARIFF ON RESIDUAL DNA TESTING MARKET
    KEY TARIFF RATES
    PRICE IMPACT ANALYSIS
    IMPACT ON COUNTRIES/REGIONS
    - North America
    - Europe
    - Asia Pacific
    - Rest of the World
    IMPACT ON END-USE INDUSTRIES
    - Pharmaceutical & biotechnology companies
    - CROs & CDMOs
    - Academic & research institutes
RESIDUAL DNA TESTING MARKET, BY OFFERING
100
  • 6.1 INTRODUCTION
  • 6.2 PRODUCTS
    CONSUMABLES
    - Increasing focus on development of biologics and biosimilars to propel segment growth
    INSTRUMENTS & SOFTWARE
    - Continuous advancement in analytical technologies to fuel segment growth
  • 6.3 SERVICES
    STRINGENT REGULATORY STANDARDS TO PROMOTE MARKET GROWTH
RESIDUAL DNA TESTING MARKET, BY TEST TYPE
116
  • 7.1 INTRODUCTION
  • 7.2 FINAL PRODUCT RELEASE TESTING
    FAVORABLE REGULATORY MANDATES AND BIOLOGICS INNOVATION TO FUEL MARKET GROWTH
  • 7.3 BULK LOT RELEASE TESTING
    INCREASING BIOLOGIC COMPLEXITY TO FUEL MARKET GROWTH
  • 7.4 RAW MATERIAL TESTING
    ENHANCED FOCUS ON PRODUCT SAFETY AND REGULATORY COMPLIANCE TO AUGMENT MARKET GROWTH
RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY
128
  • 8.1 INTRODUCTION
  • 8.2 POLYMERASE CHAIN REACTION
    HIGH THROUGHPUT DETECTION TO SUPPORT SEGMENT DOMINANCE
  • 8.3 THRESHOLD ASSAYS
    HIGH SPECIFICITY OF DNA DETECTION AT LOW CONCENTRATION TO FUEL MARKET GROWTH
  • 8.4 DNA PROBE HYBRIDIZATION
    EASY-TO-USE PORTFOLIO TO BOOST ADOPTION OF DNA PROBE HYBRIDIZATION
  • 8.5 OTHER TECHNOLOGIES
RESIDUAL DNA TESTING MARKET, BY APPLICATION
144
  • 9.1 INTRODUCTION
  • 9.2 MONOCLONAL ANTIBODIES
    EXPANSION OF BIOSIMILAR PIPELINE TO AID MARKET GROWTH
  • 9.3 CELL & GENE THERAPY
    RISING POPULARITY OF VIRAL VECTOR-BASED SYSTEMS AND INCREASING REGULATORY APPROVALS TO AID MARKET GROWTH
  • 9.4 VACCINES
    PREVALENCE OF INFECTIOUS DISEASES TO DRIVE MARKET
  • 9.5 OTHER APPLICATIONS
RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER
159
  • 10.1 INTRODUCTION
  • 10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    HIGH BIOPHARMACEUTICAL R&D SPENDING AND INCREASED REGULATORY PRESSURE TO FUEL MARKET GROWTH
  • 10.3 CROS & CDMOS
    FOCUS ON BIOLOGICS DEVELOPMENT AND CDMO FACILITY EXPANSION TO BOOST MARKET GROWTH
  • 10.4 ACADEMIC & RESEARCH INSTITUTES
    SURGE IN R&D ACTIVITIES FOR DEVELOPMENT OF ADVANCED THERAPIES TO DRIVE MARKET GROWTH
RESIDUAL DNA TESTING SERVICES MARKET, BY END USER
171
  • 11.1 INTRODUCTION
  • 11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    SURGE IN R&D INVESTMENTS IN BIOPHARMACEUTICAL INNOVATION TO PROPEL MARKET GROWTH
  • 11.3 ACADEMIC & RESEARCH INSTITUTES
    SSLIMITED IN-HOUSE CAPABILITIES TO DRIVE OUTSOURCING
RESIDUAL DNA TESTING MARKET, BY REGION
180
  • 12.1 INTRODUCTION
  • 12.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    - US to dominate North American residual DNA testing market during study period
    CANADA
    - Increasing government support for biologics manufacturing and rising research funding to propel market growth
  • 12.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - Increasing investments in biopharma and rising focus on developing manufacturing capabilities to drive market
    UK
    - Booming life science industry and growing focus on vaccine development to aid market growth
    FRANCE
    - Growing biotechnology sector and rising research funding to drive market
    ITALY
    - High R&D investments in life sciences research to augment market growth
    SPAIN
    - Increasing number of biotech companies to favor market growth
    REST OF EUROPE
  • 12.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    CHINA
    - High R&D expenditure and favorable strategic alliances to propel market growth
    JAPAN
    - Favorable government initiatives for drug development to support market growth
    INDIA
    - Increasing R&D investments and funding for life science research to support market growth
    SOUTH KOREA
    - Increasing strategic alliances and investments to spur market growth
    AUSTRALIA
    - Booming life science sector to fuel market growth
    REST OF ASIA PACIFIC
  • 12.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    - Substantial R&D investments by pharmaceutical companies to fuel market growth
    MEXICO
    - Rising government support for biopharmaceutical production to drive market
    REST OF LATIN AMERICA
  • 12.6 MIDDLE EAST
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST
    GCC COUNTRIES
    - Kingdom of Saudi Arabia
    - UAE
    - Rest of GCC Countries
    REST OF MIDDLE EAST
  • 12.7 AFRICA
    RISING PREVALENCE OF CHRONIC DISEASES AND INCREASING FUNDING FOR BIOPHARMA SECTOR TO FUEL MARKET GROWTH
    MACROECONOMIC OUTLOOK FOR AFRICA
COMPETITIVE LANDSCAPE
273
  • 13.1 INTRODUCTION
  • 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN RESIDUAL DNA TESTING MARKET
  • 13.3 REVENUE ANALYSIS, 2020–2024
  • 13.4 MARKET SHARE ANALYSIS, 2024
  • 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2024
    - Company footprint
    - Region footprint
    - Offering footprint
    - Technology footprint
    - Test type footprint
  • 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    - Detailed list of key startups/SMEs
    - Competitive benchmarking of Key startups/SMEs
  • 13.7 COMPANY VALUATION & FINANCIAL METRICS
    FINANCIAL METRICS
    COMPANY VALUATION
  • 13.8 BRAND/PRODUCT COMPARISON
  • 13.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES
    DEALS
    OTHER DEVELOPMENTS
COMPANY PROFILES
293
  • 14.1 KEY PLAYERS
    THERMO FISHER SCIENTIFIC INC.
    - Business overview
    - Products/Services offered
    - Recent developments
    - MnM view
    CHARLES RIVER LABORATORIES
    - Business overview
    - Products/Services offered
    - Recent developments
    - MnM view
    F. HOFFMANN-LA ROCHE LTD.
    - Business overview
    - Products/Services offered
    - Recent developments
    - MnM view
    MERCK KGAA
    - Business overview
    - Products/Services offered
    - Recent developments
    - MnM view
    MARAVAI LIFESCIENCES
    - Business overview
    - Products/Services offered
    - Recent developments
    - MnM view
    EUROFINS SCIENTIFIC
    - Business overview
    - Products/Services offered
    - Recent developments
    BIO-RAD LABORATORIES, INC.
    - Business overview
    - Products/Services offered
    - Recent developments
    QIAGEN
    - Business overview
    - Products/Services offered
    - Recent developments
    FUJIFILM CORPORATION
    - Business overview
    - Products/Services offered
    SGS SOCIÉTÉ GÉNÉRALE DE SURVEILLANCE SA.
    - Business overview
    - Products/Services offered
    HILLGENE BIOPHARMA CO., LTD.
    - Business overview
    - Products/Services offered
    REVVITY
    - Business overview
    - Products/Services offered
    - Recent developments
    INTERTEK GROUP PLC
    - Business overview
    - Products/Services offered
    SARTORIUS AG
    - Business overview
    - Products/Services offered
    LONZA
    - Business overview
    - Products/Services offered
    WUXI APPTEC
    - Business overview
    - Products/Services offered
  • 14.2 OTHER PLAYERS
    TRANSGEN BIOTECH CO., LTD.
    EAGLEBIO
    YEASEN
    ACROBIOSYSTEMS
    CREATIVE BIOGENE
    MINERVA BIOLABS GMBH
    CREATIVE PROTEOMICS
    AVANCE BIOSCIENCES
    GENERI BIOTECH
APPENDIX
350
  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 15.3 CUSTOMIZATION OPTIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 RESIDUAL DNA TESTING MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS
  • TABLE 3 RESIDUAL DNA TESTING MARKET: RISK ANALYSIS
  • TABLE 4 RESIDUAL DNA TESTING MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • TABLE 5 LIST OF FDA-APPROVED BIOSIMILAR PRODUCTS, 2022–2024
  • TABLE 6 KEY PRODUCT APPROVALS IN GENE THERAPY MARKET, 2022–2024
  • TABLE 7 AVERAGE SELLING PRICE TREND OF RESIDUAL DNA TESTING PRODUCTS, BY KEY PLAYER, 2022–2024 (USD MILLION)
  • TABLE 8 AVERAGE SELLING PRICE TREND OF RESIDUAL DNA QUANTIFICATION KITS, BY REGION, 2022–2024 (USD MILLION)
  • TABLE 9 AVERAGE SELLING PRICE TREND OF PCR INSTRUMENTS, BY REGION, 2022–2024 (USD MILLION)
  • TABLE 10 RESIDUAL DNA TESTING MARKET: ROLE IN ECOSYSTEM
  • TABLE 11 MAJOR INVESTMENT AND FUNDING ACTIVITIES IN RESIDUAL DNA TESTING MARKET, BY KEY PLAYER, 2022−2025
  • TABLE 12 RESIDUAL DNA TESTING MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2024
  • TABLE 13 RESIDUAL DNA TESTING MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026
  • TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 RESIDUAL DNA TESTING MARKET: PORTER’S FIVE FORCES
  • TABLE 19 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%)
  • TABLE 20 KEY BUYING CRITERIA, BY END USER
  • TABLE 21 LIST OF KEY COMPANIES IMPLEMENTING AI/GEN AI IN RESIDUAL DNA TESTING MARKET
  • TABLE 22 RESIDUAL DNA TESTING MARKET: IMPORT DATA FOR HS CODE 9027, 2020–2024 (USD THOUSAND)
  • TABLE 23 RESIDUAL DNA TESTING MARKET: EXPORT DATA FOR HS CODE 9027, 2020–2024 (USD THOUSAND)
  • TABLE 24 US ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 25 PRODUCT/COMPONENT-RELATED TARIFFS FOR RESIDUAL DNA TESTING PRODUCTS
  • TABLE 26 CRITICAL COMPONENTS EXPOSED TO TARIFF CHANGES
  • TABLE 27 RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 28 RESIDUAL DNA TESTING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 29 NORTH AMERICA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 30 EUROPE: RESIDUAL DNA TESTING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 31 ASIA PACIFIC: RESIDUAL DNA TESTING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 32 LATIN AMERICA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 33 MIDDLE EAST: RESIDUAL DNA TESTING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 34 GCC COUNTRIES: RESIDUAL DNA TESTING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 35 RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 36 RESIDUAL DNA TESTING CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 37 NORTH AMERICA: RESIDUAL DNA TESTING CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 38 EUROPE: RESIDUAL DNA TESTING CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 39 ASIA PACIFIC: RESIDUAL DNA TESTING CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 40 LATIN AMERICA: RESIDUAL DNA TESTING CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 41 MIDDLE EAST: RESIDUAL DNA TESTING CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 42 GCC COUNTRIES: RESIDUAL DNA TESTING CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 43 RESIDUAL DNA TESTING INSTRUMENTS & SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 44 NORTH AMERICA: RESIDUAL DNA TESTING INSTRUMENTS & SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 45 EUROPE: RESIDUAL DNA TESTING INSTRUMENTS & SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 46 ASIA PACIFIC: RESIDUAL DNA TESTING INSTRUMENTS & SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 47 LATIN AMERICA: RESIDUAL DNA TESTING INSTRUMENTS & SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 48 MIDDLE EAST: RESIDUAL DNA TESTING INSTRUMENTS & SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 49 GCC COUNTRIES: RESIDUAL DNA TESTING INSTRUMENTS & SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 50 RESIDUAL DNA TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 51 NORTH AMERICA: RESIDUAL DNA TESTING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 52 EUROPE: RESIDUAL DNA TESTING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 53 ASIA PACIFIC: RESIDUAL DNA TESTING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 54 LATIN AMERICA: RESIDUAL DNA TESTING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 55 MIDDLE EAST: RESIDUAL DNA TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 56 GCC COUNTRIES: RESIDUAL DNA TESTING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 57 RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
  • TABLE 58 RESIDUAL DNA FINAL PRODUCT RELEASE TESTING MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 59 NORTH AMERICA: RESIDUAL DNA FINAL PRODUCT RELEASE TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 60 EUROPE: RESIDUAL DNA FINAL PRODUCT RELEASE TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 61 ASIA PACIFIC: RESIDUAL DNA FINAL PRODUCT RELEASE TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 62 LATIN AMERICA: RESIDUAL DNA FINAL PRODUCT RELEASE TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 63 MIDDLE EAST: RESIDUAL DNA FINAL PRODUCT RELEASE TESTING MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 64 GCC COUNTRIES: RESIDUAL DNA FINAL PRODUCT RELEASE TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 65 RESIDUAL DNA BULK LOT RELEASE TESTING MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 66 NORTH AMERICA: RESIDUAL DNA BULK LOT RELEASE TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 67 EUROPE: RESIDUAL DNA BULK LOT RELEASE TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 68 ASIA PACIFIC: RESIDUAL DNA BULK LOT RELEASE TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 69 LATIN AMERICA: RESIDUAL DNA BULK LOT RELEASE TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 70 MIDDLE EAST: RESIDUAL DNA BULK LOT RELEASE TESTING MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 71 GCC COUNTRIES: RESIDUAL DNA BULK LOT RELEASE TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 72 RESIDUAL DNA RAW MATERIAL TESTING MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 73 NORTH AMERICA: RESIDUAL DNA RAW MATERIAL TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 74 EUROPE: RESIDUAL DNA RAW MATERIAL TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 75 ASIA PACIFIC: RESIDUAL DNA RAW MATERIAL TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 76 LATIN AMERICA: RESIDUAL DNA RAW MATERIAL TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 77 MIDDLE EAST: RESIDUAL DNA RAW MATERIAL TESTING MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 78 GCC COUNTRIES: RESIDUAL DNA RAW MATERIAL TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 79 RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 80 RESIDUAL DNA TESTING MARKET FOR POLYMERASE CHAIN REACTION, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 81 NORTH AMERICA: RESIDUAL DNA TESTING MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 82 EUROPE: RESIDUAL DNA TESTING MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 83 ASIA PACIFIC: RESIDUAL DNA TESTING MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 84 LATIN AMERICA: RESIDUAL DNA TESTING MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 85 MIDDLE EAST: RESIDUAL DNA TESTING MARKET FOR POLYMERASE CHAIN REACTION, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 86 GCC COUNTRIES: RESIDUAL DNA TESTING MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 87 RESIDUAL DNA TESTING MARKET FOR THRESHOLD ASSAYS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 88 NORTH AMERICA: RESIDUAL DNA TESTING MARKET FOR THRESHOLD ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 89 EUROPE: RESIDUAL DNA TESTING MARKET FOR THRESHOLD ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 90 ASIA PACIFIC: RESIDUAL DNA TESTING MARKET FOR THRESHOLD ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 91 LATIN AMERICA: RESIDUAL DNA TESTING MARKET FOR THRESHOLD ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 92 MIDDLE EAST: RESIDUAL DNA TESTING MARKET FOR THRESHOLD ASSAYS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 93 GCC COUNTRIES: RESIDUAL DNA TESTING MARKET FOR THRESHOLD ASSAYS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 94 RESIDUAL DNA TESTING MARKET FOR DNA PROBE HYBRIDIZATION, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 95 NORTH AMERICA: RESIDUAL DNA TESTING MARKET FOR DNA PROBE HYBRIDIZATION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 96 EUROPE: RESIDUAL DNA TESTING MARKET FOR DNA PROBE HYBRIDIZATION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 97 ASIA PACIFIC: RESIDUAL DNA TESTING MARKET FOR DNA PROBE HYBRIDIZATION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 98 LATIN AMERICA: RESIDUAL DNA TESTING MARKET FOR DNA PROBE HYBRIDIZATION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 99 MIDDLE EAST: RESIDUAL DNA TESTING MARKET FOR DNA PROBE HYBRIDIZATION, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 100 GCC COUNTRIES: RESIDUAL DNA TESTING MARKET FOR DNA PROBE HYBRIDIZATION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 101 RESIDUAL DNA TESTING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 102 NORTH AMERICA: RESIDUAL DNA TESTING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 103 EUROPE: RESIDUAL DNA TESTING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 104 ASIA PACIFIC: RESIDUAL DNA TESTING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 105 LATIN AMERICA: RESIDUAL DNA TESTING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 106 MIDDLE EAST: RESIDUAL DNA TESTING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 107 GCC COUNTRIES: RESIDUAL DNA TESTING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 108 RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 109 RESIDUAL DNA TESTING MARKET FOR MONOCLONAL ANTIBODIES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 110 NORTH AMERICA: RESIDUAL DNA TESTING MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 111 EUROPE: RESIDUAL DNA TESTING MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 112 ASIA PACIFIC: RESIDUAL DNA TESTING MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 113 LATIN AMERICA: RESIDUAL DNA TESTING MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 114 MIDDLE EAST: RESIDUAL DNA TESTING MARKET FOR MONOCLONAL ANTIBODIES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 115 GCC COUNTRIES: RESIDUAL DNA TESTING MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 116 RESIDUAL DNA TESTING MARKET FOR CELL & GENE THERAPY, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 117 NORTH AMERICA: RESIDUAL DNA TESTING MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 118 EUROPE: RESIDUAL DNA TESTING MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 119 ASIA PACIFIC: RESIDUAL DNA TESTING MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 120 LATIN AMERICA: RESIDUAL DNA TESTING MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 121 MIDDLE EAST: RESIDUAL DNA TESTING MARKET FOR CELL & GENE THERAPY, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 122 GCC COUNTRIES: RESIDUAL DNA TESTING MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 123 RESIDUAL DNA TESTING MARKET FOR VACCINES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 124 NORTH AMERICA: RESIDUAL DNA TESTING MARKET FOR VACCINES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 125 EUROPE: RESIDUAL DNA TESTING MARKET FOR VACCINES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 126 ASIA PACIFIC: RESIDUAL DNA TESTING MARKET FOR VACCINES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 127 LATIN AMERICA: RESIDUAL DNA TESTING MARKET FOR VACCINES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 128 MIDDLE EAST: RESIDUAL DNA TESTING MARKET FOR VACCINES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 129 GCC COUNTRIES: RESIDUAL DNA TESTING MARKET FOR VACCINES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 130 RESIDUAL DNA TESTING MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 131 NORTH AMERICA: RESIDUAL DNA TESTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 132 EUROPE: RESIDUAL DNA TESTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 133 ASIA PACIFIC: RESIDUAL DNA TESTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 134 LATIN AMERICA: RESIDUAL DNA TESTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 135 MIDDLE EAST: RESIDUAL DNA TESTING MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 136 GCC COUNTRIES: RESIDUAL DNA TESTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 137 RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 138 RESIDUAL DNA TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 139 NORTH AMERICA: RESIDUAL DNA TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 140 EUROPE: RESIDUAL DNA TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 141 ASIA PACIFIC: RESIDUAL DNA TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 142 LATIN AMERICA: RESIDUAL DNA TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 143 MIDDLE EAST: RESIDUAL DNA TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 144 GCC COUNTRIES: RESIDUAL DNA TESTING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 145 RESIDUAL DNA TESTING PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 146 NORTH AMERICA: RESIDUAL DNA TESTING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 147 EUROPE: RESIDUAL DNA TESTING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 148 ASIA PACIFIC: RESIDUAL DNA TESTING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 149 LATIN AMERICA: RESIDUAL DNA TESTING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 150 MIDDLE EAST: RESIDUAL DNA TESTING PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 151 GCC COUNTRIES: RESIDUAL DNA TESTING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 152 RESIDUAL DNA TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 153 NORTH AMERICA: RESIDUAL DNA TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 154 EUROPE: RESIDUAL DNA TESTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 155 ASIA PACIFIC: RESIDUAL DNA TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 156 LATIN AMERICA: RESIDUAL DNA TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 157 MIDDLE EAST: RESIDUAL DNA TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 158 GCC COUNTRIES: RESIDUAL DNA TESTING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 159 RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 160 RESIDUAL DNA TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 161 NORTH AMERICA: RESIDUAL DNA TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 162 EUROPE: RESIDUAL DNA TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 163 ASIA PACIFIC: RESIDUAL DNA TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 164 LATIN AMERICA: RESIDUAL DNA TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 165 MIDDLE EAST: RESIDUAL DNA TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 166 GCC COUNTRIES: RESIDUAL DNA TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 167 RESIDUAL DNA TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 168 NORTH AMERICA: RESIDUAL DNA TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 169 EUROPE: RESIDUAL DNA TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 170 ASIA PACIFIC: RESIDUAL DNA TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 171 LATIN AMERICA: RESIDUAL DNA TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 172 MIDDLE EAST: RESIDUAL DNA TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 173 GCC COUNTRIES: RESIDUAL DNA TESTING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 174 RESIDUAL DNA TESTING MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 175 RESIDUAL DNA TESTING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 176 RESIDUAL DNA TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 177 NORTH AMERICA: RESIDUAL DNA TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 178 NORTH AMERICA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 179 NORTH AMERICA: RESIDUAL DNA TESTING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 180 NORTH AMERICA: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 181 NORTH AMERICA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 182 NORTH AMERICA: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 183 NORTH AMERICA: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
  • TABLE 184 NORTH AMERICA: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 185 NORTH AMERICA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 186 NORTH AMERICA: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 187 US: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 188 US: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 189 US: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 190 US: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
  • TABLE 191 US: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 192 US: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 193 US: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 194 CANADA: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 195 CANADA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 196 CANADA: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 197 CANADA: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
  • TABLE 198 CANADA: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 199 CANADA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 200 CANADA: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 201 EUROPE: RESIDUAL DNA TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 202 EUROPE: RESIDUAL DNA TESTING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 203 EUROPE: RESIDUAL DNA TESTING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 204 EUROPE: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 205 EUROPE: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 206 EUROPE: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 207 EUROPE: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
  • TABLE 208 EUROPE: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 209 EUROPE: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 210 EUROPE: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 211 GERMANY: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 212 GERMANY: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 213 GERMANY: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 214 GERMANY: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
  • TABLE 215 GERMANY: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 216 GERMANY: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 217 GERMANY: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 218 UK: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 219 UK: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 220 UK: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 221 UK: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
  • TABLE 222 UK: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 223 UK: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 224 UK: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 225 FRANCE: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 226 FRANCE: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 227 FRANCE: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 228 FRANCE: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
  • TABLE 229 FRANCE: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 230 FRANCE: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 231 FRANCE: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 232 ITALY: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 233 ITALY: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 234 ITALY: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 235 ITALY: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
  • TABLE 236 ITALY: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 237 ITALY: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 238 ITALY: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 239 SPAIN: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 240 SPAIN: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 241 SPAIN: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 242 SPAIN: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
  • TABLE 243 SPAIN: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 244 SPAIN: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 245 SPAIN: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 246 REST OF EUROPE: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 247 REST OF EUROPE: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 248 REST OF EUROPE: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 249 REST OF EUROPE: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
  • TABLE 250 REST OF EUROPE: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 251 REST OF EUROPE: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER,2023–2030 (USD MILLION)
  • TABLE 252 REST OF EUROPE: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 253 ASIA PACIFIC: RESIDUAL DNA TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 254 ASIA PACIFIC: RESIDUAL DNA TESTING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 255 ASIA PACIFIC: RESIDUAL DNA TESTING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 256 ASIA PACIFIC: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 257 ASIA PACIFIC: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 258 ASIA PACIFIC: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 259 ASIA PACIFIC: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
  • TABLE 260 ASIA PACIFIC: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 261 ASIA PACIFIC: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 262 ASIA PACIFIC: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 263 CHINA: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 264 CHINA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 265 CHINA: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 266 CHINA: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
  • TABLE 267 CHINA: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 268 CHINA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 269 CHINA: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 270 JAPAN: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 271 JAPAN: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 272 JAPAN: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 273 JAPAN: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
  • TABLE 274 JAPAN: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 275 JAPAN: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 276 JAPAN: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 277 INDIA: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 278 INDIA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 279 INDIA: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 280 INDIA: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
  • TABLE 281 INDIA: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 282 INDIA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 283 INDIA: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 284 SOUTH KOREA: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 285 SOUTH KOREA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 286 SOUTH KOREA: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 287 SOUTH KOREA: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
  • TABLE 288 SOUTH KOREA: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 289 SOUTH KOREA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 290 SOUTH KOREA: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 291 AUSTRALIA: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 292 AUSTRALIA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 293 AUSTRALIA: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 294 AUSTRALIA: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
  • TABLE 295 AUSTRALIA: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 296 AUSTRALIA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 297 AUSTRALIA: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 298 REST OF ASIA PACIFIC: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 299 REST OF ASIA PACIFIC: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 300 REST OF ASIA PACIFIC: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 301 REST OF ASIA PACIFIC: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
  • TABLE 302 REST OF ASIA PACIFIC: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 303 REST OF ASIA PACIFIC: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 304 REST OF ASIA PACIFIC: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 305 LATIN AMERICA: RESIDUAL DNA TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 306 LATIN AMERICA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 307 LATIN AMERICA: RESIDUAL DNA TESTING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 308 LATIN AMERICA: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 309 LATIN AMERICA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 310 LATIN AMERICA: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 311 LATIN AMERICA: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
  • TABLE 312 LATIN AMERICA: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 313 LATIN AMERICA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 314 LATIN AMERICA: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 315 BRAZIL: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 316 BRAZIL: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 317 BRAZIL: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 318 BRAZIL: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
  • TABLE 319 BRAZIL: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 320 BRAZIL: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 321 BRAZIL: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 322 MEXICO: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 323 MEXICO: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 324 MEXICO: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 325 MEXICO: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
  • TABLE 326 MEXICO: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 327 MEXICO: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 328 MEXICO: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 329 REST OF LATIN AMERICA: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 330 REST OF LATIN AMERICA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 331 REST OF LATIN AMERICA: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 332 REST OF LATIN AMERICA: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
  • TABLE 333 REST OF LATIN AMERICA: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 334 REST OF LATIN AMERICA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 335 REST OF LATIN AMERICA: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 336 MIDDLE EAST: RESIDUAL DNA TESTING MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 337 MIDDLE EAST: RESIDUAL DNA TESTING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 338 MIDDLE EAST: RESIDUAL DNA TESTING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 339 MIDDLE EAST: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 340 MIDDLE EAST: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 341 MIDDLE EAST: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 342 MIDDLE EAST: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
  • TABLE 343 MIDDLE EAST: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 344 MIDDLE EAST: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 345 MIDDLE EAST: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 346 GCC COUNTRIES: RESIDUAL DNA TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 347 GCC COUNTRIES: RESIDUAL DNA TESTING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 348 GCC COUNTRIES: RESIDUAL DNA TESTING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 349 GCC COUNTRIES: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 350 GCC COUNTRIES: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 351 GCC COUNTRIES: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 352 GCC COUNTRIES: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
  • TABLE 353 GCC COUNTRIES: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 354 GCC COUNTRIES: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 355 GCC COUNTRIES: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 356 KINGDOM OF SAUDI ARABIA: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 357 KINGDOM OF SAUDI ARABIA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 358 KINGDOM OF SAUDI ARABIA: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 359 KINGDOM OF SAUDI ARABIA: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
  • TABLE 360 KINGDOM OF SAUDI ARABIA: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 361 KINGDOM OF SAUDI ARABIA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 362 KINGDOM OF SAUDI ARABIA: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 363 UAE: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 364 UAE: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 365 UAE: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 366 UAE: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
  • TABLE 367 UAE: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 368 UAE: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 369 UAE: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 370 REST OF GCC COUNTRIES: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 371 REST OF GCC COUNTRIES: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 372 REST OF GCC COUNTRIES: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 373 REST OF GCC COUNTRIES: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
  • TABLE 374 REST OF GCC COUNTRIES: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 375 REST OF GCC COUNTRIES: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 376 REST OF GCC COUNTRIES: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 377 REST OF MIDDLE EAST: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 378 REST OF MIDDLE EAST: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 379 REST OF MIDDLE EAST: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 380 REST OF MIDDLE EAST: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
  • TABLE 381 REST OF MIDDLE EAST: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 382 REST OF MIDDLE EAST: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 383 REST OF MIDDLE EAST: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 384 AFRICA: RESIDUAL DNA TESTING MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 385 AFRICA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 386 AFRICA: RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 387 AFRICA: RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
  • TABLE 388 AFRICA: RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 389 AFRICA: RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 390 AFRICA: RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 391 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN RESIDUAL DNA TESTING MARKET
  • TABLE 392 RESIDUAL DNA TESTING MARKET: DEGREE OF COMPETITION
  • TABLE 393 RESIDUAL DNA TESTING MARKET: REGION FOOTPRINT
  • TABLE 394 RESIDUAL DNA TESTING MARKET: OFFERING FOOTPRINT
  • TABLE 395 RESIDUAL DNA TESTING MARKET: TECHNOLOGY FOOTPRINT
  • TABLE 396 RESIDUAL DNA TESTING MARKET: TEST TYPE FOOTPRINT
  • TABLE 397 RESIDUAL DNA TESTING MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 398 RESIDUAL DNA TESTING MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS
  • TABLE 399 RESIDUAL DNA TESTING MARKET: PRODUCT LAUNCHES, JANUARY 2021–MAY 2025
  • TABLE 400 RESIDUAL DNA TESTING MARKET: DEALS, JANUARY 2021–MAY 2025
  • TABLE 401 RESIDUAL DNA TESTING MARKET: OTHER DEVELOPMENTS, JANUARY 2021–MAY 2025
  • TABLE 402 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 403 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 404 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2022–MAY 2025
  • TABLE 405 THERMO FISHER SCIENTIFIC INC.: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025
  • TABLE 406 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
  • TABLE 407 CHARLES RIVER LABORATORIES: PRODUCTS/SERVICES OFFERED
  • TABLE 408 CHARLES RIVER LABORATORIES: EXPANSIONS, JANUARY 2022–MAY 2025
  • TABLE 409 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
  • TABLE 410 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES OFFERED
  • TABLE 411 F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025
  • TABLE 412 MERCK KGAA: COMPANY OVERVIEW
  • TABLE 413 MERCK KGAA: PRODUCTS/SERVICES OFFERED
  • TABLE 414 MERCK KGAA: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025
  • TABLE 415 MERCK KGAA: EXPANSIONS, JANUARY 2022–MAY 2025
  • TABLE 416 MARAVAI LIFESCIENCES: COMPANY OVERVIEW
  • TABLE 417 MARAVAI LIFESCIENCES: PRODUCTS/SERVICES OFFERED
  • TABLE 418 MARAVAI LIFESCIENCES: DEALS, JANUARY 2022–MAY 2025
  • TABLE 419 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
  • TABLE 420 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED
  • TABLE 421 EUROFINS SCIENTIFIC: DEALS, JANUARY 2022–MAY 2025
  • TABLE 422 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 423 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 424 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2022–MAY 2025
  • TABLE 425 QIAGEN: COMPANY OVERVIEW
  • TABLE 426 QIAGEN: PRODUCTS/SERVICES OFFERED
  • TABLE 427 QIAGEN: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025
  • TABLE 428 FUJIFILM CORPORATION: COMPANY OVERVIEW
  • TABLE 429 FUJIFILM CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 430 SGS SOCIÉTÉ GÉNÉRALE DE SURVEILLANCE SA.: COMPANY OVERVIEW
  • TABLE 431 SGS SOCIÉTÉ GÉNÉRALE DE SURVEILLANCE SA.: PRODUCTS/SERVICES OFFERED
  • TABLE 432 HILLGENE BIOPHARMA CO., LTD.: COMPANY OVERVIEW
  • TABLE 433 HILLGENE BIOPHARMA CO., LTD.: PRODUCTS/SERVICES OFFERED
  • TABLE 434 REVVITY: COMPANY OVERVIEW
  • TABLE 435 REVVITY: PRODUCTS/SERVICES OFFERED
  • TABLE 436 REVVITY: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025
  • TABLE 437 INTERTEK GROUP PLC: COMPANY OVERVIEW
  • TABLE 438 INTERTEK GROUP PLC: PRODUCTS/SERVICES OFFERED
  • TABLE 439 SARTORIUS AG: COMPANY OVERVIEW
  • TABLE 440 SARTORIUS AG: PRODUCTS/SERVICES OFFERED
  • TABLE 441 LONZA: COMPANY OVERVIEW
  • TABLE 442 LONZA: PRODUCTS/SERVICES OFFERED
  • TABLE 443 WUXI APPTEC: COMPANY OVERVIEW
  • TABLE 444 WUXI APPTEC: PRODUCTS/SERVICES OFFERED
  • TABLE 445 TRANSGEN BIOTECH CO., LTD.: COMPANY OVERVIEW
  • TABLE 446 EAGLEBIO: COMPANY OVERVIEW
  • TABLE 447 YEASEN: COMPANY OVERVIEW
  • TABLE 448 ACROBIOSYSTEMS: COMPANY OVERVIEW
  • TABLE 449 CREATIVE BIOGENE: COMPANY OVERVIEW
  • TABLE 450 MINERVA BIOLABS GMBH: COMPANY OVERVIEW
  • TABLE 451 CREATIVE PROTEOMICS: COMPANY OVERVIEW
  • TABLE 452 AVANCE BIOSCIENCES: COMPANY OVERVIEW
  • TABLE 453 GENERI BIOTECH: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 RESIDUAL DNA TESTING MARKET SEGMENTATION & REGIONAL SCOPE
  • FIGURE 2 RESIDUAL DNA TESTING MARKET: YEARS CONSIDERED
  • FIGURE 3 RESIDUAL DNA TESTING MARKET: RESEARCH DESIGN
  • FIGURE 4 RESIDUAL DNA TESTING MARKET: BREAKDOWN OF PRIMARIES (SUPPLY- AND DEMAND-SIDE PARTICIPANTS)
  • FIGURE 5 RESIDUAL DNA TESTING MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024
  • FIGURE 6 RESIDUAL DNA TESTING MARKET: COMPANY REVENUE ANALYSIS-BASED ESTIMATION (BOTTOM-UP APPROACH) (2024)
  • FIGURE 7 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS (2024)
  • FIGURE 8 RESIDUAL DNA TESTING MARKET: INSIGHTS FROM PRIMARIES
  • FIGURE 9 RESIDUAL DNA TESTING MARKET: TOP-DOWN APPROACH
  • FIGURE 10 RESIDUAL DNA TESTING MARKET: CAGR PROJECTIONS
  • FIGURE 11 RESIDUAL DNA TESTING MARKET: DATA TRIANGULATION
  • FIGURE 12 RESIDUAL DNA TESTING MARKET, BY OFFERING, 2025 VS. 2030 (USD MILLION)
  • FIGURE 13 RESIDUAL DNA TESTING MARKET, BY TEST TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 14 RESIDUAL DNA TESTING MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
  • FIGURE 15 RESIDUAL DNA TESTING MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 16 RESIDUAL DNA TESTING PRODUCTS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 17 RESIDUAL DNA TESTING SERVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 18 REGIONAL ANALYSIS OF RESIDUAL DNA TESTING MARKET
  • FIGURE 19 INCREASE IN NUMBER OF BIOLOGICS AND BIOSIMILAR APPROVALS TO DRIVE MARKET
  • FIGURE 20 US AND FINAL PRODUCT RELEASE TESTING ACCOUNTED FOR LARGEST NORTH AMERICAN MARKET SHARE IN 2024
  • FIGURE 21 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES COMMANDED LARGEST MARKET SHARE IN 2024
  • FIGURE 22 CHINA TO WITNESS HIGHEST CAGR DURING STUDY PERIOD
  • FIGURE 23 RESIDUAL DNA TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 24 GLOBAL TOTAL PHARMACEUTICAL R&D SPEND, 2016–2030
  • FIGURE 25 RESIDUAL DNA TESTING MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
  • FIGURE 26 AVERAGE SELLING PRICE OF DNA QUANTIFICATION KITS, BY KEY PLAYER, 2024 (USD)
  • FIGURE 27 AVERAGE SELLING PRICE TREND OF PCR SYSTEMS, BY KEY PLAYER, 2022–2024 (USD)
  • FIGURE 28 AVERAGE SELLING PRICE OF RESIDUAL DNA TESTING PRODUCTS, BY REGION, 2024 (USD)
  • FIGURE 29 RESIDUAL DNA TESTING MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 30 RESIDUAL DNA TESTING MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 31 FUNDING AND NUMBER OF DEALS IN RESIDUAL DNA TESTING MARKET, 2021–2024
  • FIGURE 32 TOP APPLICANTS OF RESIDUAL DNA TESTING PATENTS, 2014–2024
  • FIGURE 33 RESIDUAL DNA TESTING MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 34 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
  • FIGURE 35 KEY BUYING CRITERIA, BY END USER
  • FIGURE 36 RESIDUAL DNA TESTING MARKET: KEY AI USE CASES
  • FIGURE 37 NORTH AMERICA: RESIDUAL DNA TESTING MARKET SNAPSHOT
  • FIGURE 38 ASIA PACIFIC: RESIDUAL DNA TESTING MARKET SNAPSHOT
  • FIGURE 39 REVENUE ANALYSIS OF KEY PLAYERS IN RESIDUAL DNA TESTING MARKET, 2020–2024 (USD MILLION)
  • FIGURE 40 MARKET SHARE ANALYSIS OF KEY PLAYERS IN RESIDUAL DNA TESTING MARKET (2024)
  • FIGURE 41 RESIDUAL DNA TESTING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 42 RESIDUAL DNA TESTING MARKET: COMPANY FOOTPRINT
  • FIGURE 43 RESIDUAL DNA TESTING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 44 WEV/EBITDA OF KEY VENDORS
  • FIGURE 45 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 46 RESIDUAL DNA TESTING MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 47 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • FIGURE 48 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT
  • FIGURE 49 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
  • FIGURE 50 MERCK KGAA: COMPANY SNAPSHOT
  • FIGURE 51 MARAVAI LIFESCIENCES: COMPANY SNAPSHOT
  • FIGURE 52 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT
  • FIGURE 53 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
  • FIGURE 54 QIAGEN: COMPANY SNAPSHOT
  • FIGURE 55 FUJIFILM CORPORATION: COMPANY SNAPSHOT
  • FIGURE 56 SGS SOCIÉTÉ GÉNÉRALE DE SURVEILLANCE SA.: COMPANY SNAPSHOT
  • FIGURE 57 HILLGENE BIOPHARMA CO., LTD.: COMPANY SNAPSHOT
  • FIGURE 58 REVVITY: COMPANY SNAPSHOT
  • FIGURE 59 INTERTEK GROUP PLC: COMPANY SNAPSHOT
  • FIGURE 60 SARTORIUS AG: COMPANY SNAPSHOT
  • FIGURE 61 LONZA: COMPANY SNAPSHOT
  • FIGURE 62 WUXI APPTEC: COMPANY SNAPSHOT

 

This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global residual DNA testing market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

Secondary research was used primarily to identify & collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include annual reports, SEC filings, investor presentations, World Health Organization (WHO), United States Food and Drug Administration (US FDA), National Center for Biotechnology Information (NCBI), Health Canada, European Medicines Agency (EMA), and Centers for Disease Control and Prevention (CDC). These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information.

The following is a breakdown of the primary respondents:

Residual DNA Testing Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the residual DNA testing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Residual DNA Testing Market

Data Triangulation

The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Residual DNA testing involves the detection and quantification of DNA impurities from host cells present in biopharmaceutical products. This testing is a critical component in the quality assurance of biologics, as it assesses the levels of residual DNA that may remain in the final product, bulk intermediates, or raw materials post-purification. The market for residual DNA testing encompasses a diverse array of analytical tools and services tailored to meet stringent regulatory requirements. Compliance with guidelines established by the FDA, WHO, and GxP standards necessitates a thorough evaluation of host cell DNA to mitigate risks and ensure safety and efficacy in biologics. This regulatory landscape makes residual DNA testing a vital focus area in the development and manufacturing of biologic products, emphasizing the need for precision and reliability in these assessments.

Stakeholders

  • Pharmaceutical & biotechnology companies
  • Academic researchers and government research organizations
  • Private research institutes
  • Custom residual DNA testing service providers
  • Contract development & manufacturing organizations (CDMOs)  
  • Life Science Companies
  • Contract research organizations (CROs)
  • Market research & consulting firms
  • Venture capitalists

Report Objectives

  • To define, describe, and forecast the global residual DNA testing market by offering, technology, test type, application, end user (product), end user (service), and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, challenges, and opportunities)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall residual DNA testing market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
  • To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • Track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the residual DNA testing market.
  • To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the residual DNA testing market.

 

Previous Versions of this Report

"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Residual DNA Testing Market

DMCA.com Protection Status